Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

LEO Pharma724 enrolled

Overview

This non-interventional, prospective, non-controlled study of Xamiol® Gel, a fixed combination of calcipotriol and betamethason dipropionate, shall investigate in daily routine the efficacy, tolerability and changes in quality-of-life parameters in patients with scalp psoriasis

Study Type

OBSERVATIONAL

Enrollment

724

Conditions

Scalp Psoriasis

Interventions

Xamiol® GelDRUG

Once daily application for about 4 weeks

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with scalp psoriasis if a treatment with Xamiol® gel is planned anyway Exclusion Criteria: * Contraindications of Xamiol® Gel listed in the German package insert * Pretreatment with Xamiol® within the last 4 weeks * Systemic treatment of psoriasis * UV light therapy

Locations (1)

University Clinical Schleswig-Holstein, Campus Kiel

Kiel, Germany

Outcomes

Primary Outcomes

Physician's Global Assessment of scalp psoriasis

Time frame: After approximately 4 weeks

Secondary Outcomes

Patient's Quality of Life

Time frame: After approximately 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.